InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Browse the detailed record of transactions filed by SPIEGELMAN DANIEL K, Director. Insider active across 1 companies, notably Myriad Genetics INC. Cumulatively, 10 filings have been logged. Total volume traded: €616k. The latest transaction was filed on 6 June 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
€115,6756,424 shares@ €18.00670.034% mcap18.8% of flow
Common Stock
SEC:0001238403-22-000002:0·
017,275 shares0
Common Stock
SEC:0001628280-22-016223:0·
€80,4093,139 shares@ €25.61620.024% mcap32.1% of flow
Common Stock
SEC:0001238403-21-000008·
€80,4093,139 shares@ €25.61620.024% mcap13.1% of flow
Common Stock
SEC:0001238403-21-000008:0·
012,848 shares0
Common Stock
SEC:0001238403-21-000006·
012,848 shares0
Common Stock
SEC:0001238403-21-000006:0·
€169,7867,142 shares@ €23.77290.050% mcap67.9% of flow
Common Stock
SEC:0001238403-21-000004·
€169,7867,142 shares@ €23.77290.050% mcap27.6% of flow
Common Stock
SEC:0001238403-21-000004:0·
015,889 shares0
Common Stock
SEC:0001238403-21-000002·
015,889 shares0
Common Stock
SEC:0001238403-21-000002:0·
10 of 10 declarations
About SPIEGELMAN DANIEL K
Daniel K. Spiegelman is a Board Member at Myriad Genetics Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights for the company's development. Daniel Spiegelman plays a key role in evaluating performance and growth opportunities.
